Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosis.
Bsteh G, Marti S, Krajnc N, Traxler G, Salmen A, Hammer H, Leutmezer F, Rommer P, Di Pauli F, Chan A, Berger T, Hegen H, Hoepner R. Bsteh G, et al. Among authors: krajnc n. Mult Scler Relat Disord. 2024 Dec 6;93:106215. doi: 10.1016/j.msard.2024.106215. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 39662164 Free article.
Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication - a retrospective multicentre study.
Di Pauli F, Riedl K, Hegen H, Auer M, Berek K, Krajnc N, Leutmezer F, Zinganell A, Berger T, Deisenhammer F, Bsteh G. Di Pauli F, et al. Among authors: krajnc n. Mult Scler Relat Disord. 2022 Jul;63:103810. doi: 10.1016/j.msard.2022.103810. Epub 2022 Apr 20. Mult Scler Relat Disord. 2022. PMID: 35477127 Free article.
Has the pandemic changed treatment strategy in multiple sclerosis?
Bsteh G, Riedl K, Krajnc N, Kornek B, Leutmezer F, Macher S, Rommer P, Zulehner G, Berger T; VMSD study group. Bsteh G, et al. Among authors: krajnc n. Mult Scler Relat Disord. 2022 Jul;63:103912. doi: 10.1016/j.msard.2022.103912. Epub 2022 May 23. Mult Scler Relat Disord. 2022. PMID: 35636274 Free PMC article.
Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study.
Krajnc N, Hegen H, Traxler G, Leutmezer F, Di Pauli F, Kornek B, Rommer P, Zulehner G, Riedl K, Dürauer S, Bauer A, Kratzwald S, Klotz S, Winklehner M, Deisenhammer F, Guger M, Höftberger R, Berger T, Bsteh G. Krajnc N, et al. Mult Scler Relat Disord. 2022 Sep;65:104009. doi: 10.1016/j.msard.2022.104009. Epub 2022 Jul 2. Mult Scler Relat Disord. 2022. PMID: 35797803 Free PMC article.
Olfactory threshold as a biomarker of long-term relapse activity in multiple sclerosis.
Berek K, Hegen H, Auer M, Barket R, Di Pauli F, Hocher J, Krajnc N, Zinganell A, Deisenhammer F, Berger T, Bsteh G. Berek K, et al. Among authors: krajnc n. Mult Scler Relat Disord. 2024 May;85:105545. doi: 10.1016/j.msard.2024.105545. Epub 2024 Mar 11. Mult Scler Relat Disord. 2024. PMID: 38479044 Free article.
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining concept.
Bsteh G, Hegen H, Krajnc N, Föttinger F, Altmann P, Auer M, Berek K, Kornek B, Leutmezer F, Macher S, Monschein T, Ponleitner M, Rommer P, Schmied C, Zebenholzer K, Zulehner G, Zrzavy T, Deisenhammer F, Di Pauli F, Pemp B, Berger T. Bsteh G, et al. Among authors: krajnc n. Mult Scler. 2024 Aug;30(9):1128-1138. doi: 10.1177/13524585241267257. Epub 2024 Aug 7. Mult Scler. 2024. PMID: 39109593 Free article.
64 results